Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,136 | -4,762 | -2,787 | -1,160 | -7,625 |
| Depreciation Amortization | 384 | 288 | 190 | 86 | 397 |
| Accounts receivable | N/A | N/A | N/A | N/A | 32 |
| Accounts payable and accrued liabilities | 169 | -247 | 346 | 177 | 144 |
| Other Working Capital | 377 | -741 | 222 | 137 | -199 |
| Other Operating Activity | 528 | 398 | -443 | -392 | 1,355 |
| Operating Cash Flow | $-7,677 | $-5,064 | $-2,472 | $-1,152 | $-5,896 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -180 | -153 | -128 | -5 | -364 |
| Investing Cash Flow | $-180 | $-153 | $-128 | $-5 | $-364 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 313 | 313 | 313 | N/A | N/A |
| Common Stock Issued | 3,556 | 7,057 | 2,544 | 570 | 5,637 |
| Other Financing Activity | 11,206 | 1,358 | 0 | 0 | 0 |
| Financing Cash Flow | $15,075 | $8,728 | $2,856 | $570 | $5,637 |
| Beginning Cash Position | 2,117 | 2,117 | 2,117 | 2,117 | 2,741 |
| End Cash Position | 9,335 | 5,629 | 2,374 | 1,530 | 2,117 |
| Net Cash Flow | $7,217 | $3,512 | $257 | $-587 | $-623 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,677 | -5,064 | -2,472 | -1,152 | -5,896 |
| Capital Expenditure | -180 | -153 | -128 | -5 | -364 |
| Free Cash Flow | -7,858 | -5,216 | -2,600 | -1,157 | -6,260 |